Abstract
The following, from the 12th OESO World Conference: Cancers of the Esophagus, includes commentaries on the animal reflux-inflammation models for Barrett's esophagus and esophageal adenocarcinoma; genomic/epigenomic analyses; eflornithine-based combinations; the molecular derangements that promote neoplastic transformation; the role of COX-2 inhibitors, proton pump inhibitors, and phase II trials in Barrett's adenocarcinoma; statins in chemoprevention and treatment of esophageal cancer; and biomarkers as potential targets in Barrett's adenocarcinoma.
| Original language | English |
|---|---|
| Pages (from-to) | 108-126 |
| Number of pages | 19 |
| Journal | Annals of the New York Academy of Sciences |
| Volume | 1325 |
| Early online date | 29 Sept 2014 |
| DOIs | |
| Publication status | Published - Sept 2014 |
| Event | 12th OESO World Conference: Cancers of the Esophagus - Paris, France Duration: 27 Aug 2013 → 30 Aug 2013 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- animal reflux–inflammation models
- Barrett's adenocarcinoma
- elofrnithine
- COXIBs
- PPIs
- statins
- biomarkers
- OESO
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver